Intolerance to cisplatin — A case report
✍ Scribed by G. E. Umbach; H. Matthiessen; G. Wirth; G. Goerz
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 149 KB
- Volume
- 236
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The spectrum of side effects induced by chemotherapy includes skin hyperpigmentation. This is prone to occur following treatment with alkylating agents and doxorubicin. More recently, hyperpigmentation was discovered in patients treated exclusively with intra-arterial cisplatin and
Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of cationic amino acid transport (CAA), relatively common in Finland and Italy. After weaning, LPI patients present poor feeding, vomiting and failure to thrive. A severe pulmonary complication and episodes of metabolic imbalan
A case of unresectable advanced gastric cancer was treated with cisdichlorodiammine platinum (CDDP) at a dosage of 30 mg/day for 5 days every month after operation. After three courses of administration, examinations revealed that the tumor had disappeared, and an evaluation of complete response was